Namely, PRA could function as a transdominant repressor of ER to inhibit ER-mediated regulation of miR-92a-3p and miR-26b-5p transcription, or directly affect the expression of these miRNA molecules, ultimately leading to reduction of the invasiveness-suppressive effect exhibited by estrogen in later phases of tumor development [89]. This evidence concerns the gene ESR1 and neoplasm.